Viewing StudyNCT02713295



Ignite Creation Date: 2024-05-06 @ 8:19 AM
Last Modification Date: 2024-10-26 @ 11:58 AM
Study NCT ID: NCT02713295
Status: COMPLETED
Last Update Posted: 2020-04-15
First Post: 2016-03-15

Brief Title: A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece
Sponsor: AbbVie
Organization: AbbVie

Conditions & Keywords Data

Conditions:
Name
Moderate to Severe Plaque Psoriasis
Keywords:
Name View
Plaque Psoriasis View
Moderate Plaque Psoriasis View
Severe Plaque Psoriasis View